BrainStorm Cell Therapeutics
BCLI
#10993
Rank
โ‚ฌ7.48 M
Marketcap
0,68ย โ‚ฌ
Share price
0.01%
Change (1 day)
14.37%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2026 (TTM): -0,92ย โ‚ฌ

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -0,96ย โ‚ฌ. In 2015 the company made an earnings per share (EPS) of -6,03ย โ‚ฌ an increase over its 2014 EPS that were of -9,11ย โ‚ฌ.

EPS history for BrainStorm Cell Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,92ย โ‚ฌ
2015-6,03ย โ‚ฌ-33.82%
2014-9,11ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Biogen
BIIB
5,07ย โ‚ฌ-630.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-2,32ย โ‚ฌ 142.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-3,58ย โ‚ฌ 274.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-6,45ย โ‚ฌ 574.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
1,80ย โ‚ฌ-288.79%๐Ÿ‡บ๐Ÿ‡ธ USA